Our ASCO20 Highlights: From Targeted Drug Study Results to New Strategies for TP53 Testing and More At the recent American Society of Clinical Oncology (ASCO) Virtual Science meeting, City of...

“During Nurses Month and Hospital Week, we thank everyone for their commitment, their efforts and their accomplishments,” said Michael Caligiuri, M.D., president of City of Hope National Medical Center...

This year, the Irell & Manella Graduate School of Biological Sciences at Beckman Research Institute of City of Hope is celebrating two graduating classes, conferring master’s and doctorate degrees...

At City of Hope, our innovative clinical and scientific research advances enable us to transform the future of health and deliver effective treatments to our patients. Our Fall 2020...

Colorectal cancer cells Recent preclinical research by Susanne G. Warner, M.D., surgical oncologist, and Yuman Fong, M.D., the Sangiacomo Family Chair in Surgical Oncology, and his team has shown...

City of Hope’s position as a leader in research and bioscience was once again evident at the recent Los Angeles Bioscience Ecosystem Summit (LABEST), the premier showcase for bioscience innovation...

Cancers of the head and neck frighten patients, but there are new methodologies that should ease minds, according to Thomas Gernon, M.D., surgeon in the Division of Head and Neck...

Don J. Diamond, Ph.D. Having previously developed a safe and efficacious Triplex vaccine to prevent incidence of cytomegalovirus infection in stem cell transplant patients with a Modified Vaccinia Ankara (MVA)...

City of Hope’s dedication to innovative research and groundbreaking advancements in the field of cancer over our 100-year history has resulted in measurable outcomes for our patients. With one of...

Phase I trial of ipatasertib in combination with chemo- and immunotherapy options   Although metastatic triple-negative breast cancer (TNBC) makes up a minority of breast cancer cases (15-20%), it is...